← Back to Dashboard

Thymalfasin

Th1 cell stimulant; Th2 cell inhibitor; Th2 cell modulator

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O…
NZVYCXVTEHPMHE-ZSUJOUNUSA-N
PubChemClinicalTrials.govPubMed

Clinical Development by Virus4

Hepacivirus C
HCV
Target: Unknown
FDA approved
Preclinical
Phase 2positive
Phase 3negative
Approved
FDA
Phase 3 ref (biospace.com) PubChem CID:16130571 NCT01178996
Hepatitis B virus
HBV
Target: Unknown
FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDA
PubChem CID:16130571 NCT03448744
Phase 2
Preclinical
Phase 2
Phase 3
Approved
NCT04487444
Human immunodeficiency virus 1
HIV-1
Target: Unknown
Preclinical
Preclinical
Phase 2
Phase 3
Approved
NCT00001036